Current Opinion in Lipidology

Papers
(The TQCC of Current Opinion in Lipidology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Genetic variation in apolipoprotein A-V in hypertriglyceridemia54
Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism52
Editorial introductions52
Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?51
Alveolar macrophages: guardians of the alveolar lipid galaxy40
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review37
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease34
ANGPTL4: a new mode in the regulation of intravascular lipolysis34
Sphingomyelins and ceramides: possible biomarkers for dementia?31
Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?30
Implementation science and genetic testing for familial hypercholesterolemia29
The lipid-heart hypothesis from the Seven Countries Study of Cardiovascular Diseases29
Lipid metabolism during pregnancy: consequences for mother and child28
Familial hypercholesterolemia: The nexus of endothelial dysfunction and lipoprotein metabolism in COVID-1928
Oxidized LDL receptors: a recent update27
Familial hypercholesterolemia in children and the importance of early treatment26
Lipoprotein(a) and peripheral artery disease: contemporary evidence and therapeutic advances24
Editorial introductions22
Exosomes and lipid metabolism in metabolic and cardiovascular disorders22
Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutations18
Nonalcoholic fatty liver disease: an update18
Nutrition and its impact on cardiovascular disease17
The current state of apolipoprotein E in dyslipidemia17
Genetic determinants of pancreatitis risk in hypertriglyceridemia16
A new SPRING in lipid metabolism15
Familial hypercholesterolemia in pregnancy15
Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia14
From clinical development to real-world outcomes with inclisiran14
Lipid effects of glucagon-like peptide 1 receptor analogs14
Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent13
The intracellular chylomicron highway: novel insights into chylomicron biosynthesis, trafficking, and secretion13
APOE and familial hypercholesterolemia13
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?13
The need for national and international registries of patients with elevated lipoprotein(a)13
Are the lipid-lowering effects of incretin-based therapies relevant for cardiovascular benefit?13
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives13
Can small dense LDL cholesterol be estimated from the lipid profile?12
Newborn screening for lipid disorders12
The emerging role of fat-inducing transcript 2 in endoplasmic reticulum proteostasis and lipoprotein biogenesis11
Editorial introductions11
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease10
Genetic testing for familial hypercholesterolemia10
Cardiomyocytes, sphingolipids and cardio myotoxicity10
Preprint servers in lipidology: current status and future role10
Pregnancy, cardiovascular health, and microchimerism10
Recent dynamic studies of the metabolism of atherogenic lipoproteins: elucidating the mode of action of new therapies10
Distinct roles of size-defined HDL subpopulations in cardiovascular disease10
Clinical associations between exercise and lipoproteins10
Altered cardiovascular risk pattern of LDL cholesterol in older adults9
Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review9
Metabolic regulation of macrophage proliferation and function in atherosclerosis9
Association of dietary patterns and components with atherosclerosis risk biomarkers in familial hypercholesterolemia9
Prevention of cardiometabolic diseases through dietary modifications8
LDL receptor-related protein 1 and its interacting partners in tissue homeostasis8
Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment8
Strategies for management of patients with elevated lipoprotein(a)8
0.050711154937744